Airtame Launches Airtame Cloud, Signaling New Focus on Combined Hardware and Software Offering
15.1.2020 16:00:00 EET | Business Wire | Press release
Airtame, the leading wireless screen sharing and collaboration platform, today announced the official launch of Airtame Cloud, a new software-as-a-service product designed to make screens smarter. The open platform offers device management and access to a range of digital signage solutions, helping users create smarter offices, workplaces and schools with their screens.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200115005060/en/
Airtame Cloud (Graphic: Business Wire)
Airtame Cloud -- which has been available in beta for over a year, and is already used by 6,500 organizations globally -- is a unified platform that enables users to manage and update their screens remotely. It was built on an open ecosystem that seamlessly integrates with a range of applications that can be used to create tailored digital signage, such as Google Slides, Microsoft OneDrive, Trello, Dropbox, and YouTube, with more integrations to come.
Cloud will allow users to:
- Manage screens remotely, freeing up IT administrators to change settings and conduct bulk updates with cloud access to Airtame-enabled screens
- Boost productivity and engagement, with personalized digital signage in meeting rooms, classrooms and common areas
- Save on power, by scheduling screens to turn on and off according to office or school hours
- Avoid blank screens, by scheduling imagery and videos to play on loop
The launch of Cloud marks the evolution of Airtame as it continues to grow from a hardware to solution-centric business, with a strong focus on facilitating smart offices and schools around the world.
“With Airtame Cloud, we’re providing a solution that empowers our customers to boost engagement and productivity for employees, students and visitors, whether that be in the office, meeting room or classroom,” said Airtame Co-Founder and Co-CEO Jonas Gyalokay.
“Part of our vision at Airtame is to help enterprises and schools create smarter offices and classrooms. While this starts with screens, we imagine one day it could extend to all aspects of the workplace or classroom, with the potential to automate lighting, sound, room temperature and more.
“With the evolution of IoT, the possibilities to connect devices and screens are endless. As a starting point, Airtame Cloud will help schools and enterprises reduce their energy consumption by automating screens to turn off when they’re not being used. We’re looking forward to embracing technology to build additional hardware and software features of this kind in the future.”
Airtame Cloud will launch with two plans: Airtame Cloud Lite, a free version of the product that offers the essential features needed to manage and update Airtame devices, and Airtame Cloud Plus, a premium version that enables digital signage and additional features needed to create a smart office or classroom.
The launch follows a series of important milestones for Airtame, including the recent announcement of its industry-first partnership with Airserver. The company has enjoyed 100% YoY growth since its market launch in 2014.
ENDS
Access the full press kit containing imagery and video materials here.
ABOUT AIRTAME:
Airtame offers a wireless screen sharing and collaboration platform that allows users to instantly display content from any personal device to any shared screen. The platform is used to promote interactivity and collaboration in meetings, presentations and classroom settings, as well as for digital signage in retail stores, corporate environments, conference facilities, hotels, and other venues. Airtame was launched in 2014 and has grown into a company with 100+ people, and with offices in New York, Los Angeles, Copenhagen, and Budapest.
To learn more, visit www.airtame.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200115005060/en/
Contact information
Martin Stockfleth Larsen
Airtame
+45 31 661 663
martin.larsen@airtame.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
